Treatment update on acromegaly
Pegvisomant is a new drug that blocks growth hormone peripheralreceptors, allowing normalization of insulin-like growth factor-1levels and consequently of clinical symptoms, reducing morbidityand mortality associated with acromegaly in almost all patients.Its introduction made us review the literatu...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2004-12-01
|
| Series: | Einstein (São Paulo) |
| Subjects: | |
| Online Access: | http://www.einstein.br/biblioteca/artigos/Vol2Num4/Treatment%20update%20on%20acromegaly_02.pdf |